Transcatheter ablation and modulation of AV node and anomalous pathways

M. Lunati, M. Gasparini, G. Magenta, G. Cattafi, G. Maccabelli, B. Brusoni, G. Gadaleta

Research output: Contribution to journalArticle

Abstract

We report our experience of transcatheter ablation in pts with SV tachyarrhythmias. We started our experience with DC shock ablation in 1987 and moved toward RF current in mid 1991. Up to now 80 pts with drug refractory arrhythmias have been treated with this technique (DC: 70 pts, RF 10 pts). AV nodal ablation: Sixty pts with paroxysmal or chronic A.F. were referred for AV junctional ablation. AV block was produced in 58/60 (96,6%) and subsequently VVI RR or DDD RR PM were implanted. At a mean follow up of 19,9 months AV block persisted in 58; exercise capacity and quality of life significantly improved in more than 85% of the pts. Modification of AV junction in AV nodal reentry tachycardia: Nine consecutive pts underwent perinodal modulation. In 9/9 (100%) retrograde conduction was abolished or significantly impaired. One pt had complete AV block and had PM implanted. At a mean follow up of 12,4 months 8 pts had no recurrence of SVT, 1 pt developed paroxismal A.F., successfully treated with drugs. Ablation of accessory pathways: Eleven pts with overt (7) and concealed (4) pathways underwent transcatheter ablation of Kent bundle (5 posteroseptal, 3 anteroseptal, 1 midseptal, 1 right lateral, 1 left posterior). The procedure was effective in 9/11 pts (84,8%). Two pts resumed conduction of anomalous pathways that were subsequently ablated by the surgeon. One third degree AV block occurred and a PM was implanted. In conclusion the technique appears to be safe and effective, even if not simple and time consuming, and hopefully the treatment of choice of many SV tachyarrhythmias.

Original languageEnglish
Pages (from-to)459-467
Number of pages9
JournalNew Trends in Arrhythmias
Volume8
Issue number1-2
Publication statusPublished - 1992

Fingerprint

Atrioventricular Node
Atrioventricular Block
Tachycardia
Accessory Atrioventricular Bundle
Dichlorodiphenyldichloroethane
Pharmaceutical Preparations
Cardiac Arrhythmias
Shock
Quality of Life
Exercise
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lunati, M., Gasparini, M., Magenta, G., Cattafi, G., Maccabelli, G., Brusoni, B., & Gadaleta, G. (1992). Transcatheter ablation and modulation of AV node and anomalous pathways. New Trends in Arrhythmias, 8(1-2), 459-467.

Transcatheter ablation and modulation of AV node and anomalous pathways. / Lunati, M.; Gasparini, M.; Magenta, G.; Cattafi, G.; Maccabelli, G.; Brusoni, B.; Gadaleta, G.

In: New Trends in Arrhythmias, Vol. 8, No. 1-2, 1992, p. 459-467.

Research output: Contribution to journalArticle

Lunati, M, Gasparini, M, Magenta, G, Cattafi, G, Maccabelli, G, Brusoni, B & Gadaleta, G 1992, 'Transcatheter ablation and modulation of AV node and anomalous pathways', New Trends in Arrhythmias, vol. 8, no. 1-2, pp. 459-467.
Lunati M, Gasparini M, Magenta G, Cattafi G, Maccabelli G, Brusoni B et al. Transcatheter ablation and modulation of AV node and anomalous pathways. New Trends in Arrhythmias. 1992;8(1-2):459-467.
Lunati, M. ; Gasparini, M. ; Magenta, G. ; Cattafi, G. ; Maccabelli, G. ; Brusoni, B. ; Gadaleta, G. / Transcatheter ablation and modulation of AV node and anomalous pathways. In: New Trends in Arrhythmias. 1992 ; Vol. 8, No. 1-2. pp. 459-467.
@article{761698e6d4dd4c98b4ba661fb5d732f7,
title = "Transcatheter ablation and modulation of AV node and anomalous pathways",
abstract = "We report our experience of transcatheter ablation in pts with SV tachyarrhythmias. We started our experience with DC shock ablation in 1987 and moved toward RF current in mid 1991. Up to now 80 pts with drug refractory arrhythmias have been treated with this technique (DC: 70 pts, RF 10 pts). AV nodal ablation: Sixty pts with paroxysmal or chronic A.F. were referred for AV junctional ablation. AV block was produced in 58/60 (96,6{\%}) and subsequently VVI RR or DDD RR PM were implanted. At a mean follow up of 19,9 months AV block persisted in 58; exercise capacity and quality of life significantly improved in more than 85{\%} of the pts. Modification of AV junction in AV nodal reentry tachycardia: Nine consecutive pts underwent perinodal modulation. In 9/9 (100{\%}) retrograde conduction was abolished or significantly impaired. One pt had complete AV block and had PM implanted. At a mean follow up of 12,4 months 8 pts had no recurrence of SVT, 1 pt developed paroxismal A.F., successfully treated with drugs. Ablation of accessory pathways: Eleven pts with overt (7) and concealed (4) pathways underwent transcatheter ablation of Kent bundle (5 posteroseptal, 3 anteroseptal, 1 midseptal, 1 right lateral, 1 left posterior). The procedure was effective in 9/11 pts (84,8{\%}). Two pts resumed conduction of anomalous pathways that were subsequently ablated by the surgeon. One third degree AV block occurred and a PM was implanted. In conclusion the technique appears to be safe and effective, even if not simple and time consuming, and hopefully the treatment of choice of many SV tachyarrhythmias.",
author = "M. Lunati and M. Gasparini and G. Magenta and G. Cattafi and G. Maccabelli and B. Brusoni and G. Gadaleta",
year = "1992",
language = "English",
volume = "8",
pages = "459--467",
journal = "New Trends in Arrhythmias",
issn = "0393-5302",
number = "1-2",

}

TY - JOUR

T1 - Transcatheter ablation and modulation of AV node and anomalous pathways

AU - Lunati, M.

AU - Gasparini, M.

AU - Magenta, G.

AU - Cattafi, G.

AU - Maccabelli, G.

AU - Brusoni, B.

AU - Gadaleta, G.

PY - 1992

Y1 - 1992

N2 - We report our experience of transcatheter ablation in pts with SV tachyarrhythmias. We started our experience with DC shock ablation in 1987 and moved toward RF current in mid 1991. Up to now 80 pts with drug refractory arrhythmias have been treated with this technique (DC: 70 pts, RF 10 pts). AV nodal ablation: Sixty pts with paroxysmal or chronic A.F. were referred for AV junctional ablation. AV block was produced in 58/60 (96,6%) and subsequently VVI RR or DDD RR PM were implanted. At a mean follow up of 19,9 months AV block persisted in 58; exercise capacity and quality of life significantly improved in more than 85% of the pts. Modification of AV junction in AV nodal reentry tachycardia: Nine consecutive pts underwent perinodal modulation. In 9/9 (100%) retrograde conduction was abolished or significantly impaired. One pt had complete AV block and had PM implanted. At a mean follow up of 12,4 months 8 pts had no recurrence of SVT, 1 pt developed paroxismal A.F., successfully treated with drugs. Ablation of accessory pathways: Eleven pts with overt (7) and concealed (4) pathways underwent transcatheter ablation of Kent bundle (5 posteroseptal, 3 anteroseptal, 1 midseptal, 1 right lateral, 1 left posterior). The procedure was effective in 9/11 pts (84,8%). Two pts resumed conduction of anomalous pathways that were subsequently ablated by the surgeon. One third degree AV block occurred and a PM was implanted. In conclusion the technique appears to be safe and effective, even if not simple and time consuming, and hopefully the treatment of choice of many SV tachyarrhythmias.

AB - We report our experience of transcatheter ablation in pts with SV tachyarrhythmias. We started our experience with DC shock ablation in 1987 and moved toward RF current in mid 1991. Up to now 80 pts with drug refractory arrhythmias have been treated with this technique (DC: 70 pts, RF 10 pts). AV nodal ablation: Sixty pts with paroxysmal or chronic A.F. were referred for AV junctional ablation. AV block was produced in 58/60 (96,6%) and subsequently VVI RR or DDD RR PM were implanted. At a mean follow up of 19,9 months AV block persisted in 58; exercise capacity and quality of life significantly improved in more than 85% of the pts. Modification of AV junction in AV nodal reentry tachycardia: Nine consecutive pts underwent perinodal modulation. In 9/9 (100%) retrograde conduction was abolished or significantly impaired. One pt had complete AV block and had PM implanted. At a mean follow up of 12,4 months 8 pts had no recurrence of SVT, 1 pt developed paroxismal A.F., successfully treated with drugs. Ablation of accessory pathways: Eleven pts with overt (7) and concealed (4) pathways underwent transcatheter ablation of Kent bundle (5 posteroseptal, 3 anteroseptal, 1 midseptal, 1 right lateral, 1 left posterior). The procedure was effective in 9/11 pts (84,8%). Two pts resumed conduction of anomalous pathways that were subsequently ablated by the surgeon. One third degree AV block occurred and a PM was implanted. In conclusion the technique appears to be safe and effective, even if not simple and time consuming, and hopefully the treatment of choice of many SV tachyarrhythmias.

UR - http://www.scopus.com/inward/record.url?scp=0026713748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026713748&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 459

EP - 467

JO - New Trends in Arrhythmias

JF - New Trends in Arrhythmias

SN - 0393-5302

IS - 1-2

ER -